Mercury Systems (NASDAQ:MRCY – Get Free Report) was downgraded by equities research analysts at StockNews.com from a “hold” rating to a “sell” rating in a report issued on Thursday. Several other research firms have also commented on MRCY. JPMorgan Chase & Co. increased their price objective on shares of Mercury Systems from $26.00 to $36.00 […]

StockNews.com initiated coverage on shares of NortonLifeLock (NASDAQ:NLOK – Free Report) in a research note published on Wednesday. The firm issued a buy rating on the stock. NortonLifeLock Stock Performance Shares of NLOK opened at $26.48 on Wednesday. The company has a market capitalization of $15.13 billion, a price-to-earnings ratio of 18.79 and a beta […]

BTIG Research initiated coverage on shares of Definitive Healthcare (NASDAQ:DH – Free Report) in a research report released on Tuesday, Marketbeat reports. The firm issued a buy rating and a $7.00 price objective on the stock. A number of other research firms have also recently commented on DH. Morgan Stanley reduced their price objective on […]

Cantor Fitzgerald restated their overweight rating on shares of Ascendis Pharma A/S (NASDAQ:ASND – Free Report) in a report released on Monday morning, Benzinga reports. They currently have a $170.00 target price on the biotechnology company’s stock. Cantor Fitzgerald also issued estimates for Ascendis Pharma A/S’s FY2024 earnings at ($6.54) EPS. A number of other […]

BioMarin Pharmaceutical (NASDAQ:BMRN – Free Report) had its price objective decreased by Scotiabank from $95.00 to $78.00 in a research report released on Tuesday morning, Benzinga reports. Scotiabank currently has a sector perform rating on the biotechnology company’s stock. Other analysts have also issued reports about the company. Wells Fargo & Company dropped their target […]

The Goldman Sachs Group started coverage on shares of Fidelis Insurance (NYSE:FIHL – Free Report) in a research report released on Tuesday, MarketBeat reports. The firm issued a neutral rating and a $18.50 price objective on the stock. Other research analysts have also recently issued research reports about the stock. JMP Securities restated a market […]

Cantor Fitzgerald restated their overweight rating on shares of Mereo BioPharma Group (NASDAQ:MREO – Free Report) in a research report sent to investors on Monday, Benzinga reports. Cantor Fitzgerald currently has a $7.00 target price on the stock. MREO has been the subject of several other research reports. Needham & Company LLC restated a buy […]

Cantor Fitzgerald reiterated their overweight rating on shares of UnitedHealth Group (NYSE:UNH – Free Report) in a research note published on Monday morning, Benzinga reports. The firm currently has a $591.00 target price on the healthcare conglomerate’s stock. Several other research analysts have also recently weighed in on the company. Jefferies Financial Group upgraded UnitedHealth […]